Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
3(25%)
Results Posted
75%(6 trials)

Phase Distribution

Ph not_applicable
10
83%
Ph phase_2
1
8%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
1(8.3%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(4)
Completed(8)

Detailed Status

Completed8
Recruiting3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (8.3%)
Phase 31 (8.3%)
N/A10 (83.3%)

Trials by Status

recruiting325%
completed867%
enrolling_by_invitation18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12